A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC
- Status
- RECRUITING
- Phase
- N/A
Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Breast Cancer Evolution During Neoadjuvant Systemic Therapy
- Status
- RECRUITING
- Phase
- N/A
Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TNBC Gut Microbiota During Neoadjuvant Treatment
- Status
- RECRUITING
- Phase
- NA
Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Breast Cancer PSMA PET
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Status
- RECRUITING
- Phase
- PHASE1
FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2